Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

Piloting an mHealth-delivered Mindfulness Therapy With Patients With Serious Illness and Their Caregivers to Alleviate Symptoms of Anxiety

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Older adults with serious illness and their caregivers have high rates of anxiety and limited access to effective, non-pharmacological treatments. A recent National Academy of Medicine report recommended increased emphasis on disseminating and implementing evidence-based psychotherapies in order to have maximal public health impact. Through this work, I will identify a sustainable and potentially scalable dyadic intervention and delivery model to manage symptoms of anxiety in older adults with serious illness and their caregivers in primary care.

Who May Be Eligible (Plain English)

Who May Qualify: - adults 60+ - Diagnosis of or caregiver for individual with serious illnesses (e.g., ESRD, Cancer, CHF, COPD, Liver Disease) - Hads-A \> 8 for patient or caregiver - Blessed\<6 - fluent in English - vision and hearing does not interfere with mobile device use - caregivers who must be 21+ - caregiver must identify as primary source of informal care for patient - Caregiver blessed \<6 - caregiver is fluent in English - Caregiver's vision and hearing does not interfere with mobile device use. Who Should NOT Join This Trial: - experience with mindfulness therapy in last 2 years - not fluent in English - vision or hearing that impairs use of mobile device - cognitive impairment more than 6 on Blessed. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * adults 60+ * Diagnosis of or caregiver for individual with serious illnesses (e.g., ESRD, Cancer, CHF, COPD, Liver Disease) * Hads-A \> 8 for patient or caregiver * Blessed\<6 * fluent in English * vision and hearing does not interfere with mobile device use * caregivers who must be 21+ * caregiver must identify as primary source of informal care for patient * Caregiver blessed \<6 * caregiver is fluent in English * Caregiver's vision and hearing does not interfere with mobile device use. Exclusion Criteria: * experience with mindfulness therapy in last 2 years * not fluent in English * vision or hearing that impairs use of mobile device * cognitive impairment more than 6 on Blessed.

Treatments Being Tested

BEHAVIORAL

Mindfulness Coach

This study will use Mindfulness Coach, an iOS- and Android-based app designed to deliver a mindfulness training course centered on Veteran's Affairs (VA) protocols. Developed by the VA's National Center for PTSD, the app provides an engaging introduction to MT, regardless of specific psychiatric illness or patient population. The app provides a training plan with 14 sequential levels, a "practice now" area with evidence-based mindfulness audio exercises, assessments using the Five-Factor Mindfulness Questionnaire Short Form (FFMQ-SF)90, and education about mindfulness. To progress to the next level, the user must interact with every element. The training plan levels include psychoeducation and exercises (guided meditations and seated practices), which increase in duration as users progress. Levels 1,7 and 14 also include an assessment with the FFMQ-SF. The "practice now" area has guided meditations to practice new skills.

BEHAVIORAL

Active Comparator

A a widely available health and wellness app that provides users with daily content on general health, WebMD, will serve as the attention control. Similar health-based apps have been used as controls in other mHealth psychotherapy intervention trials.100,101 The control group will be instructed to access the app 4x/week (same as intervention group) and will receive an orientation and 2 booster sessions as well. I considered other control group options including treatment as usual, but attention control was selected due to the variability of treatment as usual.

Locations (3)

RWJ Barnabas Outpatient Geriatric Clinics
Livingston, New Jersey, United States
RWJB Outpatient Geriatrics
Monroe, New Jersey, United States
Cancer Institute of New Jersey
New Brunswick, New Jersey, United States